- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01007786
The Ventricular Catheter Placement Study: Assessment of Efficacy and Safety of an Ultrasound Guided Shunt Insertion Technique
June 12, 2012 updated by: University of Utah
Shunt failure remains a significant problem in pediatric patients with hydrocephalus.
If reliable techniques for the accurate placement of ventricular catheters can be developed, shunt survival may improve.
The purpose of this study is to assess the efficacy and safety of the ultrasound guided shunt insertion technique in the hands of experienced surgeons.
The primary outcome measure is ventricular catheter location determined from post-operative brain images.
The study is being conducted by the Hydrocephalus Clinical Research Network (HCRN), a network established to conduct multi-institutional clinical trials on pediatric hydrocephalus.
Pediatric neurosurgeons at HCRN centers enrolled in this study will perform either ultrasound guided shunt surgery or a conventional shunt surgery.
Patients who undergo conventional shunt surgery will serve as a contemporary control group.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
67
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- Sick Children's Hospital
-
-
-
-
Alabama
-
Birmingham, Alabama, United States, 35233
- Children's Hospital of Alabama
-
-
Texas
-
Houston, Texas, United States, 77030
- Texas Children's Hospital
-
-
Utah
-
Salt Lake City, Utah, United States, 84113
- Primary Children's Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Pediatric hydrocephalus patients undergoing first time shunt placement for hydrocephalus.
Description
Inclusion Criteria:
- Patients must have clinical and radiographic evidence of hydrocephalus as determined by a pediatric neurosurgeon and require a ventriculoperitoneal shunt (atrial, pleural, gallbladder and other shunt systems are excluded)
- Patients can have no prior history of shunt insertion for hydrocephalus. A history of an external ventricular drain, subgaleal reservoir-catheter, or subgaleal shunt is permissible
- Patients must be less than 18 years of age at the time of shunt insertion
Exclusion Criteria:
- Active CSF or abdominal infection
- Spread of tumor in the subarachnoid space documented on enhanced imaging (CT or MRI) of the head or spine
- CSF leak without hydrocephalus
- Pseudotumor cerebri
- Dandy-Walker malformation or arachnoid cyst as a cause of hydrocephalus
- Loculations within the ventricular system
- Hydranencephaly, alobar holoprosencephaly or any other congenital anomaly of the brain that severely distorts the ventricular anatomy such that ventricular catheter location cannot be determined
- Other systemic disorders that would preclude the insertion/revision of a ventricular shunt
- Other difficulties that would preclude follow-up at one year (e.g. terminal illness with life expectancy less than 1 year)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The primary endpoint for the study is ventricular catheter location (VCL) as assessed on the first post-operative scan (US, CT, or MRI brain).
Time Frame: The first post-operative scan will only be used in the study if it occurs within 105 days of shunt insertion.
|
The first post-operative scan will only be used in the study if it occurs within 105 days of shunt insertion.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Shunt survival will be reported.
Time Frame: Up to one year after the date of shunt placement.
|
Up to one year after the date of shunt placement.
|
|
Any complications, intraoperative and postoperative, will be reported.
Time Frame: From the time of surgery until the time the subject is discharged from the hospital.
|
From the time of surgery until the time the subject is discharged from the hospital.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: William Whitehead, MD, MPH, HCRN, Texas Children's Hospital
- Principal Investigator: Jay Riva-Cambrin, MD, HCRN, Primary Children's Medical Center
- Principal Investigator: Abhaya Kulkarni, MD, PhD, HCRN, Sick Children's Hospital, Toronto, Ontario
- Principal Investigator: Jay Wellons, MD, HCRN, Children's Hosptial of Alabama
- Principal Investigator: John Kestle, MD, Chair, Hydrocephalus Clinical Research Network
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2008
Primary Completion (Actual)
February 1, 2010
Study Completion (Actual)
March 1, 2011
Study Registration Dates
First Submitted
November 2, 2009
First Submitted That Met QC Criteria
November 2, 2009
First Posted (Estimate)
November 4, 2009
Study Record Updates
Last Update Posted (Estimate)
June 14, 2012
Last Update Submitted That Met QC Criteria
June 12, 2012
Last Verified
June 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 32371
- 1RC1NS068943-01 (U.S. NIH Grant/Contract)
- HCRN 002 (Other Identifier: HCRN Protocol Number)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Hydrocephalus
-
University of UtahNational Institute of Neurological Disorders and Stroke (NINDS)RecruitingPediatric HydrocephalusUnited States, Canada
-
Hande GurbuzBursa Yüksek İhtisas Education and Research HospitalCompletedPediatric Anesthesia | Hydrocephalus in Children | Regional BlockTurkey
-
Assiut UniversityNot yet recruitingPostoperative Complications | Bacterial Infections and Mycoses | Prosthesis-Related Infections | Hydrocephalus | Hydrocephalus in Children | Hydrocephalus in Infants | Pediatric Hydrocephalus | Surgical Site Infection (SSI) | Ventriculoperitoneal Shunt Infection | Cerebrospinal Fluid Shunt InfectionEgypt
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompleted
-
Göteborg UniversityDepartment of Neurological Surgery, Sahlgrenska University Hospital; Hydrocephalus... and other collaboratorsNot yet recruitingNormal Pressure Hydrocephalus | Normal Pressure Hydrocephalus Patients
-
Mayo ClinicTerminatedNormal Pressure Hydrocephalus PatientsUnited States
-
Umeå UniversityCompleted
-
Dokuz Eylul UniversityRecruitingNPH (Normal Pressure Hydrocephalus)Turkey
-
Second Affiliated Hospital, School of Medicine,...Westlake UniversityRecruitingIdiopathic Normal Pressure HydrocephalusChina
-
University of ZurichCompletedIdiopathic Normal Pressure HydrocephalusSwitzerland